LianBio Sponsored ADR LIANY
0.06
0.00
0.00%
as of 25 Sep
- Market cap
- $34.2M
- P/E
- 0.0×
Follow LIANY
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 12.96 | 44.45 | 26.48 | 13.24 | 17.03 | 74.19 | 1,466.00 |
Net Debt/EBITDA |
— | 1.75 | 1.89 | 1.96 | 2.43 | 5.77 | 1.36 | 7.41 |
Debt/Assets |
0.00% | 1.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.48 | 0.70 | 0.84 | 0.90 | 0.83 | 1.51 | 1.01 |
Capex/Depreciation |
— | — | (11.66) | (1.80) | (1.83) | (0.28) | 0.00 | — |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 32.79% | 245.17% | (135.72%) | (32.39%) | 70.96% | 0.77% | 11.75% | |
| — | (111.09%) | (86.40%) | (55.64%) | (29.56%) | 66.19% | 0.73% | 11.63% | |
ROIC |
— | 0.00% | 0.00% | (2,990.73%) | 0.00% | (450.47%) | (217.43%) | (7.12%) |
Return on Tangible Assets |
— | (60.13%) | (51.45%) | (50.80%) | (37.74%) | 53.56% | 3.94% | 23.88% |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
— | (0.11) | (8.22) | (4.79) | (0.94) | 2.40 | 0.03 | 0.05 |
Cash per Share |
— | 0.40 | 21.11 | 11.14 | 2.80 | 5.26 | 0.48 | 0.09 |
Shareholders Equity per Share |
— | 0.36 | (8.14) | 11.26 | 2.72 | 5.39 | 0.58 | 0.19 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.36 | (8.14) | 11.26 | 2.72 | 5.39 | 0.58 | 0.19 |
Free Cash Flow |
— | (11.72) | (99.03) | (164.90) | (101.03) | 258.79 | 3.75 | 4.94 |
Working Capital |
— | 40.00 | 270.52 | 384.56 | 289.16 | 577.44 | 62.87 | 20.51 |
Capital Expenditures |
— | — | (0.89) | (0.95) | (1.84) | (0.37) | — | — |
Net Current Asset Value |
— | 39.65 | (100.61) | 360.64 | 286.46 | 576.70 | 62.87 | 20.51 |
| Other line items | ||||||||
Quick Ratio |
— | 12.94 | 44.07 | 25.79 | 12.88 | 16.86 | 71.99 | 1,399.29 |
Depreciation/Fixed assets |
— | 0.00 | 0.09 | 0.28 | 0.32 | 0.63 | 0.00 | — |
Cash ROIC |
— | (14.76%) | (63.32%) | (21.52%) | (17.16%) | 22.38% | 3.27% | 16.52% |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.11) | (8.14) | (4.77) | (0.92) | 2.40 | 0.03 | 0.05 |
Capex per Share |
— | 0.00 | (0.07) | (0.03) | (0.02) | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | 13.02 | 3.91 | 20.84 | 25.03 | 10.17 |
Average Payables |
— | — | — | 3.78 | 2.34 | 2.74 | 2.09 | — |
Average Assets |
— | 21.94 | 161.58 | 352.81 | 373.15 | 468.96 | 340.84 | 42.12 |
Average Common Equity |
— | (74.33) | (56.94) | 144.63 | 340.49 | 437.42 | 322.03 | 41.69 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates